Health Boards


My Profile

Health Boad

Health Jobs


Health Tools

hu14.18-interleukin-2 fusion protein

An anticancer drug in which hu14.18, a monoclonal antibody, is combined with interleukin-2. The monoclonal antibody binds to the cancer cells and delivers IL-2, which stimulates the immune system to destroy the cancer cells.

Selected hu14.18-interleukin-2 fusion protein links:

© 1997-2005 is a purely informational website, and should not be used as a substitute for professional legal, medical or technical advice.